InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
glenn1919 PremiumMember
03/09/24 10:19 AM
profile icon
Awl416 Free
03/04/24 8:39 AM
profile icon
glenn1919 PremiumMember
03/03/24 1:55 PM
profile icon
Monksdream PremiumMember
10/30/23 12:39 PM
profile icon
Monksdream PremiumMember
10/09/23 4:01 PM
profile icon
seve333 Free
09/25/23 5:28 PM
profile icon
sc00pnDump Free
09/22/23 7:45 AM
profile icon
81vette Free
08/08/23 8:55 AM
profile icon
AJ Freely Free
08/07/23 7:47 AM
profile icon
DavidTrader Free
03/27/23 1:14 PM
Bullish
Bullish
profile icon
Lilman72003 Free
03/22/23 4:17 PM
profile icon
DewDiligence PremiumMember
04/14/22 5:23 PM
profile icon
Frankestin Free
03/14/22 10:36 AM
profile icon
DewDiligence PremiumMember
03/14/22 9:57 AM
profile icon
DewDiligence PremiumMember
02/17/21 10:21 AM
profile icon
ClayTrader Free
01/15/20 4:41 PM
profile icon
Sluicebox Free
01/11/20 7:21 AM
profile icon
czni Free
12/14/19 5:36 PM
profile icon
czni Free
12/14/19 5:27 PM
profile icon
czni Free
12/14/19 5:11 PM
profile icon
czni Free
12/14/19 5:04 PM
profile icon
czni Free
12/14/19 5:01 PM
profile icon
czni Free
12/14/19 4:53 PM
profile icon
Clemdane Free
12/11/19 11:44 AM
profile icon
whytestocks Free
12/09/19 10:45 PM
profile icon
whytestocks Free
12/09/19 7:15 PM
profile icon
whytestocks Free
12/09/19 6:30 PM
profile icon
whytestocks Free
11/10/19 11:15 AM
profile icon
whytestocks Free
11/09/19 6:04 PM
profile icon
ClayTrader Free
10/08/19 6:05 PM
profile icon
behindthebid Free
08/09/19 8:58 AM
profile icon
DewDiligence PremiumMember
08/08/19 5:20 PM
profile icon
DewDiligence PremiumMember
08/08/19 4:25 PM
profile icon
jondoeuk Free
08/06/19 4:54 PM
profile icon
whytestocks Free
08/01/19 4:50 PM
profile icon
jondoeuk Free
02/25/19 5:35 PM
profile icon
jondoeuk Free
12/29/18 3:43 PM
profile icon
jondoeuk Free
11/25/18 3:58 PM
profile icon
DewDiligence PremiumMember
11/09/18 6:46 PM
profile icon
jondoeuk Free
11/08/18 12:30 PM
profile icon
DewDiligence PremiumMember
11/07/18 6:45 PM

Nektar Therapeutics (NKTR) RSS Feed

Followers
36
Posters
64
Posts (Today)
0
Posts (Total)
281
Created
10/20/05
Type
Free
Moderators
http://www.nektar.com

http://finance.yahoo.com/q?s=NKTR


Nektar Therapeutics, a biopharmaceutical company, develops various drug products and product candidates using its proprietary drug delivery technologies. Its technology platforms comprise PEGylation Technology designed to enhance the performance of various drug classes, including macromolecules, small molecules, and other drugs; and Pulmonary Technology, which includes technologies for drug formulation, powder processing, powder filling, and packaging, as well as dry powder inhaler devices and liquid nebulizer devices. The company's technologies are used in 10 approved products; 3 partner programs that have been filed for with the FDA; and 12 development programs in human clinical trials. Its partnered products include Tobramycin inhalation powder, a Phase III clinical product for treating lung infections; NKTR-061, a Phase II clinical product for gram-negative pneumonias; Ciprofloxacin Inhalation Powder, a Phase II clinical product for lung infections; Pulmonary dronabinol, a Phase II product for migraine; and Exubera Inhalation Powder for adult type 1 and type 2 diabetes. The company's partnered product portfolio also comprises Neulasta for neutropenia; PEGASY for Hepatitis-C; Somavert for Acromegaly; PEG-INTRON for Hepatitis-C; Macugen for age-related macular degeneration; CIMZIA for Crohn's disease; MIRCERA for renal anemia and chronic kidney disease; CIMZIA for rheumatoid arthritis; Hematide, a Phase III product for Anemia; Macugen, a Phase II clinical trial product for diabetic macular edema and retinal vein occlusion; and CDP 791, a Phase II product for nonsmall cell lung cancer. In addition, Nektar's proprietary products include NKTR-102, a Phase II trial product for colorectal cancer; and NKTR-118, which is in Phase II clinical trials for opioid-induced constipation and other manifestations of opioid bowel dysfunction. The company was founded in 1990 and is headquartered in San Carlos, California.


Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
New Post